Qilu Pharmaceutical Co., Ltd.

This large Phase 3 trial is comparing a new drug combination (QL1706 plus chemotherapy) against a standard treatment for patients with advanced non-small cell lung cancer that has spread and tests negative for a specific biomarker called PD-L1. The study aims to see if the new co…

This study aims to see if a new fertility hormone injection called QL1012D acts similarly in the body to an already approved drug called Gonal-F. It will involve 48 healthy female volunteers who will receive both drugs in a random order. Researchers will measure hormone levels in…

This early-stage study aims to see how a new drug candidate, QL2106, compares to an existing psoriasis drug called Tremfye in healthy volunteers. Researchers will give a single dose to 190 healthy adults and closely track how the body processes each drug, its safety, and how the …